Angion Biomedica (ANGN) – FDA
-
Angion Biomedica (ANGN) Discontinues Phase 2 Trial of ANG-3070 Due to Safety Concerns
-
Angeion Corp (ANGN) Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis
-
-
-
-
-
-
-
Back to ANGN Stock Lookup